Abstract:

This study has been conducted specifically to explore the experiences of people living with HIV/AIDS and taking antiretroviral medications in Nairobi. This study specifically sought to: describe individuals’ feelings before and after initiation of antiretroviral medications; ascertain whether there is stigma associated with taking antiretroviral medications; Identify support mechanisms available for people taking antiretroviral medications; describe challenges individuals face as a result of taking antiretroviral medications, and establish coping mechanisms available for antiretroviral medication related challenges.

This study was a cross sectional qualitative inquiry that used in-depth interviews to explore the experiences of people on antiretroviral medications in Nairobi. The results showed that before taking antiretroviral medications, participants were feeling hopeless, sad and frustrated. However, when they started the antiretroviral medications, their feelings changed positively to feelings of hope and courage. Family support is crucial for good adherence to antiretroviral medications; though these medications pose the greatest challenge of treatment side effects. In summary, this study showed that antiretroviral medications are a greatest investment in the physical, medical and psychosocial welfare for people living with HIV/AIDS.

References:

[1.] Chantler. (2005). From disconnection to connection: Race, gender and the politics of therapy. British Journal of Guidance & Counselling, 33(2), pp. 239-256.

[2.] Dlamini, P.S., Wantland, D., Makoae, L.N., Chirwa, M., Kohi, T.W., Greeff, M., … Holzemer, W. L. (2009). HIV-stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care STDS, 23(5), pp. 377_387. and psychological adjustment to HIV/AIDS. Psychosomatics, 44(6), pp. 485-491.

[3.] Gilbert, L., & Walker, L. (2009). Stigma as experienced by patients in an HIV/AIDS Clinic in Johannesburg, South Africa. Health & Social Care in the Community, 18(2), 139_146.

[4.] Kaai, S., Avina, S., Luchters, S., Geibel, S., Munyao, P., Mandaliya, K., Shikely, K., Temmerman, M., and Rutenberg, N. (2007). Changes in stigma among a cohort of people on antiretroviral therapy: Findings from Mombasa, Kenya. Nairobi: Population Council HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, pp. 89-102.

[5.] Logie, C., & Gadalla, T.M. (2009). Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care, 21(6), pp.742-753.

[6.] Pearson, C.R., Micek, M.A., Pfeiffer, J., Montoya, P., Matediane, E., Jonasse, T., Gloyd, S. (2009). One year after ART initiation: Psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS and Behaviour, 13(6), pp.1189-1196.

[7.] Rogers, C. (1951). Client-Centred Therapy.: Constable: London

[8.] Simbayi, L.C., Kalichman, S., Strebel, A., Cloete, A., Henda, N., & Nqeketo, A. (2007). Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Social Science & Medicine, 64(9), pp.1823_1831.

[9.] Smith, R., Rossetto, K., & Peterson, B.L. (2008). A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care, 20(10), pp.1266-1275.

[10.] UNAIDS. (2009). Annual Report, 2009: UNAIDS. Geneva:

[11.] Wolfe et al. (2008). The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. American journal of Public Health 98(10), pp. 1865-1871.

[12.] Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, pp. 810–816.